BRAFTOVI 50 MG CAP DURA CT BL AL AL X 28
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1211004830011 -
GGREM
522723010091201 -
Código de barras
7891045164948
O que a fonte publica
- Detentor do registro
- PFIZER BRASIL LTDA
- Princípios ativos
- ENCORAFENIBE
- Embalagem
- 50 MG CAP DURA CT BL AL AL X 28
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Novo
- Classe terapêutica
- L1H4 - INIBIDORES PREOTEÍNA KINASE ANTINEOPLÁSICOS, BRAF/MEK
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "BRAFTOVI 50 MG CAP DURA CT BL AL AL X 28",
"holder": "PFIZER BRASIL LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7891045164948"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "522723010091201",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "61.072.393/0001-33",
"priceRegime": "Regulado",
"productName": "BRAFTOVI",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "50 MG CAP DURA CT BL AL AL X 28",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "3391.56",
"icms-12": "3854.05",
"icms-17": "4086.22",
"icms-18": "4136.05",
"icms-19": "4187.11",
"icms-20": "4239.45",
"icms-21": "4293.11",
"icms-22": "4348.15",
"icms-23": "4404.62",
"icms-17.5": "4110.98",
"icms-19.5": "4213.12",
"icms-20.5": "4266.11",
"icms-22.5": "4376.21",
"icms-12-alc": "3441.11",
"icms-17-alc": "3648.41",
"icms-18-alc": "3692.90",
"icms-19-alc": "3738.49",
"icms-20-alc": "3785.22",
"icms-21-alc": "3833.14",
"icms-22-alc": "3882.28",
"icms-23-alc": "3932.70",
"withoutTaxes": "3028.18",
"icms-17.5-alc": "3670.52",
"icms-19.5-alc": "3761.71",
"icms-20.5-alc": "3809.03",
"icms-22.5-alc": "3907.32"
},
"pisCofinsList": "Negativa",
"substanceText": "ENCORAFENIBE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "4549.66",
"icms-12": "5170.07",
"icms-17": "5481.52",
"icms-18": "5548.36",
"icms-19": "5616.86",
"icms-20": "5687.07",
"icms-21": "5759.05",
"icms-22": "5832.89",
"icms-23": "5908.64",
"icms-17.5": "5514.73",
"icms-19.5": "5651.75",
"icms-20.5": "5722.83",
"icms-22.5": "5870.53",
"icms-12-alc": "4757.13",
"icms-17-alc": "5043.71",
"icms-18-alc": "5105.22",
"icms-19-alc": "5168.24",
"icms-20-alc": "5232.84",
"icms-21-alc": "5299.09",
"icms-22-alc": "5367.02",
"icms-23-alc": "5436.73",
"withoutTaxes": "4186.28",
"icms-17.5-alc": "5074.28",
"icms-19.5-alc": "5200.34",
"icms-20.5-alc": "5265.76",
"icms-22.5-alc": "5401.64"
},
"invalidBarcodes": [],
"activeSubstances": [
"ENCORAFENIBE"
],
"therapeuticClass": "L1H4 - INIBIDORES PREOTEÍNA KINASE ANTINEOPLÁSICOS, BRAF/MEK",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1211004830011",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L1H4",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:522723010091201"